Alberto O. Stella
Sydney, NSW, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Clinical Pharmacology Approaches to Predict Efficacy of Monoclonal Antibodies Against Emerging SARS-CoV-2 Variants.
Journal: Clinical and translational science
Published: September 18, 2025
Novel siRNA therapeutics demonstrate multi-variant efficacy against SARS-CoV-2.
Journal: Antiviral research
Published: April 21, 2023
Fibroblast-expressed LRRC15 is a receptor for SARS-CoV-2 spike and controls antiviral and antifibrotic transcriptional programs.
Journal: PLoS biology
Published: November 16, 2022
High titre neutralizing antibodies in response to SARS-CoV-2 infection require RBD-specific CD4 T cells that include proliferative memory cells.
Journal: Frontiers in immunology
Published: August 31, 2022
SARS-CoV-2 Omicron BA.5: Evolving tropism and evasion of potent humoral responses and resistance to clinical immunotherapeutics relative to viral variants of concern.
Journal: EBioMedicine
Published: July 07, 2022
High-Titer Neutralizing Antibodies against the SARS-CoV-2 Delta Variant Induced by Alhydroxyquim-II-Adjuvanted Trimeric Spike Antigens.
Journal: Microbiology spectrum
Published: February 16, 2022
Patients with treated indolent lymphomas immunized with BNT162b2 have reduced anti-spike neutralizing IgG to SARS-CoV-2 variants, but preserved antigen-specific T cell responses.
Journal: American journal of hematology
Published: January 24, 2022
Platform for isolation and characterization of SARS-CoV-2 variants enables rapid characterization of Omicron in Australia.
Journal: Nature microbiology
Published: December 28, 2021
SARS-CoV-2 Omicron variant escapes neutralizing antibodies and T cell responses more efficiently than other variants in mild COVID-19 convalescents.
Journal: Cell reports. Medicine
Published: December 08, 2021
Embedding of HIV Egress within Cortical F-Actin.
Journal: Pathogens (Basel, Switzerland)
Published: November 12, 2021
Maintenance of broad neutralizing antibodies and memory B cells 1 year post-infection is predicted by SARS-CoV-2-specific CD4+ T cell responses.
Journal: Cell reports
Published: September 07, 2021
Last Updated: 09/26/2026